TGF-β, secreted by cancer cells or other cell types in the surrounding microenvironment, also encourages GBM neovascularization, mainly by augmenting the levels of the pro-angiogenic factor insulin-like growth factor-binding protein 7 (IGFBP7) in the tumor endothelial fraction [168]. This evidence concerns the gene IGFBP7 and cancer.